Action Medical Research “Host-derived mitochondrial transduction for the treatment of neonatal hypoxic-ischemic brain injury”. PI C. Thornton, Co-Is H. Stolp, T. Eykyn, R. Southworth. £57,798. 01/11/2020 → 31/10/2021
Rosetrees Trust “Montelukast actions in the brain; potential therapy for perintal brain injury”. PI H. Stolp, Co-Is C. Thornton, P. Gressens, G. Woszczek £30,000 1/04/2019 → 31/03/2021
Bloomsbury Studentship “Development and plasticity of structural and functional networks in the mouse brain” (3-year PhD studentship). PI: H. Stolp, Co-I M. Thomas 1/09/2018 → 31/08/2020
King’s Health Partners, “Evaluating Montelukast as novel therapeutic for preterm brain injury using 3D-BOND analysis”. PI H. Stolp, Co-Is C. Thornton, P. Gressens, D. Batalle. £78,049 15/11/2017 → 14/11/2018
King’s Health Partners, “A novel mitoprotective therapy to tackle neonatal encephalopathy”. PI C. Thornton, Co-Is H. Stolp, H. Hagberg. £75,620 1/08/2016 → 28/02/2018
Medical Research Council “Zika: Cellular mechanisms of microcephaly due to Zika virus infection in mice”. PI Z. Molnar, Co-Is H. Stolp, P. Garcez, F. Tovar-Moll, R. Lent.£79,926 31/03/2016 → 30/09/2017
SPARKS Charity “Montelukast, a potential anti-inflammatory treatment for preterm brain injury. PI H. Stolp, Co-Is C. Thornton, P. Gressens. £148,275 1/04/2016 → 30/09/2018
King’s Health Partners, “MRI-See; Clarifying perinatal brain injury”. PI C. Thornton, Co-Is H. Stolp, G. Ball, A, Kichev, P. So. £96,921 1/02/2014 → 28/02/2016
BRC Stem Early Career Award, £3788 training award 2013
European Union Seventh Framework Programme [FP7/2007- 2013] under grant agreement HEALTH-F2-2009-241778 “NEUROBID: Neuroscience on Barriers in Development”. Consortium members: MHH, INSERM, UMC Utrecht, UOXF, Simcyp, UNIMELB, UGOT, Brain-I, ABT, UKW. University of Oxford team: Z. Molnar, D. Anthony, N. Sibson, H. Stolp, funded to £238,752. 4/04/2009 → 28/04/2013 http://www.neurobid.eu/
Neurodevelopmental Injury Laboratory 